<code id='F62008399B'></code><style id='F62008399B'></style>
      • <acronym id='F62008399B'></acronym>
      <center id='F62008399B'><center id='F62008399B'><tfoot id='F62008399B'></tfoot></center><abbr id='F62008399B'><dir id='F62008399B'><tfoot id='F62008399B'></tfoot><noframes id='F62008399B'>
      • <optgroup id='F62008399B'><strike id='F62008399B'><sup id='F62008399B'></sup></strike><code id='F62008399B'></code></optgroup>
        5. <b id='F62008399B'><label id='F62008399B'><select id='F62008399B'><dt id='F62008399B'><span id='F62008399B'></span></dt></select></label></b><u id='F62008399B'></u>
          <i id='F62008399B'><strike id='F62008399B'><tt id='F62008399B'><pre id='F62008399B'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / knowledge / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-09-27 13:33:26 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：667
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Review: 'Barbie' will hit you like a shot in the heart
                                
                            
          Next article：  
                                      
                                          Dobbs anniversary: the lost opportunity of abortion as health care
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles